Construction of infectious SIV/HIV-2 chimeras.
OBJECTIVE
To construct SIV/HIV-2 chimeras (SHIV) that replicate in vivo. These would be valuable tools to elucidate the mechanism by which HIV-2 can bypass protection conferred by live attenuated SIV vaccines.


METHODS
Novel SHIV were constructed to express either the vpx, vpr, tat, rev and env genes (SHIV-2isy env) or the gag and pol genes (SHIV-2isy gag/pol) of the infectious molecular clone HIV-2isy in an SIVmac backbone. The replication of SHIV-2isy env and SHIV-2isy gag/pol were evaluated on selected cell lines and peripheral blood mononuclear cells (PBMC) in vitro. In addition, their infectivity was assessed in vivo.


RESULTS
Virus stocks of SHIV-2isy env and SHIV-2isy gag/pol were prepared in vitro. For SHIV-2isy gag/pol both the 5' and 3' boundaries of the chimeric construct were critical for infectivity in vitro. The growth of each chimera on T cell lines in vitro mirrors that of the parental viruses donating the envelope gene. On PBMCs SHIV-2isy env replicated well on human and simian PBMC whereas SHIV-2isy gag/pol replicated to detectable levels on human PBMC only. In vivo, SHIV-2isy env virus was isolated from one of two cynomolgus macaques challenged intravenously, SHIV-2isy gag/pol was isolated from one of two cynomolgus macaques and both rhesus macaques challenged intravenously.


CONCLUSIONS
This is the first report of SIV/HIV-2 chimeras that are infectious in macaques. Moreover, this is the first report of an infectious chimera in which both SIV gag and pol have been replaced with the equivalent regions of an HIV isolate.
Ranjbar
S
S
Division of Retrovirology, National Institute for Biological Standards and Control, South Mimms, Potters Bar, UK.
Bhattacharya
U
U
Oram
J
J
Stott
E J
EJ
Almond
N
N
D000818:Animals; D002460:Cell Line; D015658:HIV Infections / Q000503:physiopathology / Q000821:virology; D015498:HIV-2 / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D008252:Macaca fascicularis; D008253:Macaca mulatta; D008992:Monkey Diseases / Q000503:physiopathology / Q000821:virology; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D016097:Simian Acquired Immunodeficiency Syndrome / Q000503:physiopathology / Q000821:virology; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology; D014779:Virus Replication
D011993:Recombinant Fusion Proteins